Literature DB >> 30853200

Central Line-Associated Blood Stream Infections and Non-Central Line-Associated Blood Stream Infections Surveillance in Canadian Tertiary Care Neonatal Intensive Care Units.

Amy R Zipursky1, Eugene W Yoon2, Julie Emberley3, Valerie Bertelle4, Jaideep Kanungo5, Shoo K Lee6, Prakesh S Shah7.   

Abstract

OBJECTIVE: To determine if the reported reduction in hospital-acquired infections is due to reduced central line-associated blood stream infections (CLABSI) or non-CLABSIs. STUDY
DESIGN: A retrospective cohort study design was used to describe the change in organism pattern and incidence of hospital-acquired infections (CLABSIs and non-CLABSIs) in neonates <33 weeks of gestation admitted to tertiary neonatal intensive care units in the Canadian Neonatal Network between January 1, 2010, and December 31, 2016. Hospital-acquired infection was diagnosed when a pathogenic organism was isolated from blood or cerebrospinal fluid in a neonate with suspected sepsis. CLABSI was diagnosed when a central venous catheter was present at the time or removed in the 2 days before a hospital-acquired infection diagnosis. Cochran-Armitage and Mann-Kendall trend tests and linear regression models were used for statistical analyses.
RESULTS: Of 28 144 eligible neonates from 30 Canadian Neonatal Network neonatal intensive care units, 3306 (11.7%) developed hospital-acquired infections. There was a significant decrease in the rate of hospital-acquired infections (14.2% in 2010 and 9.2% in 2016; P < .01), and the rate of both CLABSIs and non-CLABSIs (P < .01) over the study period concomitant with a significant decrease in the duration of central line use (P = .01). The rates of meningitis also decreased during the study period (1.2% in 2010 and 0.9% in 2016; P < .01). Infections owing to gram-positive cocci significantly decreased, but infections owing to gram-negative organisms remained unchanged.
CONCLUSION: Although there was a significant decrease in CLABSIs and non-CLABSIs, hospital-acquired infections in preterm neonates remained high. Infections owing to gram-negative organisms remained unchanged and are a target for future preventative efforts. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  central-line associated blood stream infections; gram negative; gram positive; hospital-acquired infections; neonatal intensive care unit; preterm

Mesh:

Year:  2019        PMID: 30853200     DOI: 10.1016/j.jpeds.2018.12.011

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Diagnosis of Neonatal Late-Onset Infection in Very Preterm Infant: Inter-Observer Agreement and International Classifications.

Authors:  Gaelle Bury; Stéphanie Leroux; Cristhyne Leon Borrego; Christèle Gras Leguen; Delphine Mitanchez; Geraldine Gascoin; Aurore Thollot; Jean Michel Roué; Guy Carrault; Patrick Pladys; Alain Beuchée
Journal:  Int J Environ Res Public Health       Date:  2021-01-20       Impact factor: 3.390

2.  Evaluation of the Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants With Late-Onset Infection.

Authors:  Noa Fleiss; Sarah A Coggins; Angela N Lewis; Angela Zeigler; Krista E Cooksey; L Anne Walker; Ameena N Husain; Brenda S de Jong; Aaron Wallman-Stokes; Mhd Wael Alrifai; Douwe H Visser; Misty Good; Brynne Sullivan; Richard A Polin; Camilia R Martin; James L Wynn
Journal:  JAMA Netw Open       Date:  2021-02-01

3.  A longitudinal analysis of nosocomial bloodstream infections among preterm neonates.

Authors:  Sophie J Jansen; Alieke van der Hoeven; Thomas van den Akker; Marieke Veenhof; Erik G J von Asmuth; Karin Ellen Veldkamp; Monique Rijken; Martha van der Beek; Vincent Bekker; Enrico Lopriore
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-09-30       Impact factor: 5.103

4.  Risk Factors of Nosocomial Infection for Infants in Neonatal Intensive Care Units: A Systematic Review and Meta-Analysis.

Authors:  Li Wang; Ke-Ning Du; Yan-Ling Zhao; Ya-Juan Yu; Li Sun; Hong-Bo Jiang
Journal:  Med Sci Monit       Date:  2019-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.